Head of Strategic Finance and Investor Relations, Jounce Tx & MassBio BD/Finance Forum Co-Chair
Komal Joshi is the head of strategic finance and investor relations at Jounce Therapeutics, a clinical-stage immunotherapy company that is developing therapies that enable the immune system to attack tumors and provide long-lasting benefits to cancer patients. Prior to Komal’s transition to industry, she spent 15+ years in financial services, beginning with her role as a sell-side equity research analyst. Komal then moved to healthcare investment banking where she executed on capital raising and M&A advisory for emerging to large cap healthcare product and services companies. Altogether, she brings almost 20 years of increasing industry and financial services experiences. Komal has a BS in Finance from Boston College and an MBA from Columbia Business School.